1. Home
  2. IGC
  3. IGC News

Latest IGC Pharma Inc. (IGC) News on June 22, 2025

IGC

ACCESS Newswire

a month ago

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market

IGC

ACCESS Newswire

a month ago

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

IGC Pharma Welcomes Strategic Investment from Advisors
IGC

ACCESS Newswire

2 months ago

IGC Pharma Welcomes Strategic Investment from Advisors

IGC

ACCESS Newswire

2 months ago

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs

IGC Pharma expands CALMA trial with addition of Butler Hospital Program
IGC

TipRanks

2 months ago

IGC Pharma expands CALMA trial with addition of Butler Hospital Program

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program
IGC

ACCESS Newswire

2 months ago

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health
IGC

ACCESS Newswire

3 months ago

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances
IGC

ACCESS Newswire

3 months ago

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences
IGC

ACCESS Newswire

3 months ago

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences

IGC

ACCESS Newswire

3 months ago

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida

IGC

ACCESS Newswire

3 months ago

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25"

IGC

ACCESS Newswire

3 months ago

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results"

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection
IGC

ACCESS Newswire

4 months ago

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection

IGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’
IGC

TipRanks

4 months ago

IGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market
IGC

ACCESS Newswire

4 months ago

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market

IGC

ACCESS Newswire

4 months ago

IGC Pharma Reports Third Quarter Fiscal 2025 Results

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM)
IGC

ACCESS Newswire

4 months ago

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM)

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease
IGC

ACCESS Newswire

5 months ago

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor
IGC

ACCESS Newswire

5 months ago

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
IGC

ACCESS Newswire

5 months ago

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

IGC

ACCESSWIRE

5 months ago

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy

IGC

ACCESSWIRE

6 months ago

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025

IGC

ACCESSWIRE

7 months ago

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
IGC

Business Wire

7 months ago

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
IGC

ACCESSWIRE

7 months ago

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline

IGC

ACCESSWIRE

8 months ago

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies

IGC

ACCESSWIRE

8 months ago

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
IGC

ACCESSWIRE

9 months ago

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
IGC

Business Wire

9 months ago

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease
IGC

Business Wire

10 months ago

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease

IGC Announces Results of its 2024 Annual Stockholders Meeting
IGC

Business Wire

10 months ago

IGC Announces Results of its 2024 Annual Stockholders Meeting

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
IGC

Business Wire

10 months ago

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist
IGC

Business Wire

10 months ago

IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist

IGC Pharma Reports First Quarter Fiscal 2025 Results
IGC

Business Wire

10 months ago

IGC Pharma Reports First Quarter Fiscal 2025 Results

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target
IGC

Business Wire

a year ago

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target

Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
IGC

Business Wire

a year ago

Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
IGC

Business Wire

a year ago

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
IGC

Business Wire

a year ago

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
IGC

Business Wire

a year ago

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
IGC

Business Wire

a year ago

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
IGC

Business Wire

a year ago

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

IGC Pharma to Attend BIO International Convention 2024
IGC

Business Wire

a year ago

IGC Pharma to Attend BIO International Convention 2024

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
IGC

Business Wire

a year ago

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

IGC Pharma Adds Advisor in Artificial Intelligence
IGC

Business Wire

a year ago

IGC Pharma Adds Advisor in Artificial Intelligence

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
IGC

Business Wire

a year ago

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
IGC

Business Wire

a year ago

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation

IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
IGC

Business Wire

a year ago

IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
IGC

Business Wire

a year ago

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
IGC

Business Wire

a year ago

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
IGC

Business Wire

a year ago

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target

IGC Pharma Reports Third Quarter Fiscal 2024 Results
IGC

Business Wire

a year ago

IGC Pharma Reports Third Quarter Fiscal 2024 Results

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
IGC

Business Wire

a year ago

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer
IGC

GlobeNewswire

a year ago

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
IGC

Business Wire

a year ago

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation
IGC

Simply Wall St.

a year ago

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Jewelry Looking Grimy? Here’s How to Clean It at Home
IGC

The Wall Street Journal

a year ago

Jewelry Looking Grimy? Here’s How to Clean It at Home

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
IGC

Business Wire

a year ago

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
IGC

InvestorPlace

a year ago

Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation
IGC

PR Newswire

a year ago

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
IGC

GuruFocus.com

a year ago

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Pathward Financial, Inc. to Announce First Quarter 2024 Earnings and Host Conference Call on January 24, 2024
IGC

Business Wire

a year ago

Pathward Financial, Inc. to Announce First Quarter 2024 Earnings and Host Conference Call on January 24, 2024

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023
IGC

GlobeNewswire

a year ago

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

CardRatings Unveils Its ‘Best Credit Cards of 2024’ List and Annual Cardholder Survey Results
IGC

Business Wire

a year ago

CardRatings Unveils Its ‘Best Credit Cards of 2024’ List and Annual Cardholder Survey Results

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
IGC

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
IGC

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
IGC

Zacks

a year ago

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems
IGC

PR Newswire

a year ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
IGC

GlobeNewswire

a year ago

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Parke Bancorp (NASDAQ:PKBK) Has Announced A Dividend Of $0.18
IGC

Simply Wall St.

a year ago

Parke Bancorp (NASDAQ:PKBK) Has Announced A Dividend Of $0.18

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript
IGC

Insider Monkey

a year ago

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
IGC

Business Wire

2 years ago

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s

Finance of America Receives Continued Listing Standard Notice from the NYSE
IGC

Business Wire

2 years ago

Finance of America Receives Continued Listing Standard Notice from the NYSE

Positive Signs As Multiple Insiders Buy Chimerix Stock
IGC

Simply Wall St.

2 years ago

Positive Signs As Multiple Insiders Buy Chimerix Stock

IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
IGC

Business Wire

2 years ago

IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024

Navitas “Electrify Our World™” at CES 2024
IGC

GlobeNewswire

2 years ago

Navitas “Electrify Our World™” at CES 2024

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
IGC

Business Wire

2 years ago

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
IGC

GlobeNewswire

2 years ago

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

ClearSign Technologies (NASDAQ:CLIR) delivers shareholders notable 98% return over 1 year, surging 59% in the last week alone
IGC

Simply Wall St.

2 years ago

ClearSign Technologies (NASDAQ:CLIR) delivers shareholders notable 98% return over 1 year, surging 59% in the last week alone

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
IGC

Business Wire

2 years ago

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives

Finance of America Chooses Spera Security to Bolster its Identity Security
IGC

GlobeNewswire

2 years ago

Finance of America Chooses Spera Security to Bolster its Identity Security

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates
IGC

Zacks

2 years ago

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates

OrbiMed Advisors LLC Reduces Stake in Kinnate Biopharma Inc
IGC

GuruFocus.com

2 years ago

OrbiMed Advisors LLC Reduces Stake in Kinnate Biopharma Inc

IGC

Business Wire

2 years ago

BlackRock Enhanced Government Fund, Inc. Announces Expiration of Annual Repurchase Offer

IGC Pharma Reports Second Quarter Fiscal 2024 Results
IGC

Business Wire

2 years ago

IGC Pharma Reports Second Quarter Fiscal 2024 Results

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript
IGC

Insider Monkey

2 years ago

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

WideOpenWest, Inc. (NYSE:WOW) Q3 2023 Earnings Call Transcript
IGC

Insider Monkey

2 years ago

WideOpenWest, Inc. (NYSE:WOW) Q3 2023 Earnings Call Transcript

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts
IGC

Simply Wall St.

2 years ago

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million
IGC

GuruFocus.com

2 years ago

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th
IGC

Business Wire

2 years ago

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th

This Broker Just Slashed Their ARB IOT Group Limited (NASDAQ:ARBB) Earnings Forecasts
IGC

Simply Wall St.

2 years ago

This Broker Just Slashed Their ARB IOT Group Limited (NASDAQ:ARBB) Earnings Forecasts

Aware Inc (AWRE) Q3 2023 Earnings: Revenue Soars by 112% to $6.4 Million
IGC

GuruFocus.com

2 years ago

Aware Inc (AWRE) Q3 2023 Earnings: Revenue Soars by 112% to $6.4 Million

aTyr Pharma to Present at November Investor Conferences
IGC

GlobeNewswire

2 years ago

aTyr Pharma to Present at November Investor Conferences

Share on Social Networks: